Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Selleck Chemical LLC LQZ-7I-E0108-25MG
Supplier: Selleck Chemical LLC E010825MG
LQZ-7I is a novel selectively inhibitor of survivin dimerization with IC50s of 4 8 M and 3 1 M in prostate cancer cell lines PC-3 and C4-2 respectively LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?